Octreotide

Comprehensive Product Overview

In the advanced field of peptide therapeutics, the precision of the molecular structure defines the final clinical efficacy. Zyntex Octreotide is selected for its ability to mimic natural somatostatin with a significantly longer half-life and higher potency. Therefore, we utilize sophisticated solid-phase peptide synthesis (SPPS) and rigorous purification techniques to ensure a high-purity profile. Consequently, this versatile ingredient delivers reliable performance in suppressing growth hormone and various gastrointestinal peptides across a wide range of clinical conditions.

Zyntex supplies Octreotide in a stable lyophilized powder form, optimized for easy integration into specialized sterile fill-finish processes. Our stringent quality control measures ensure high purity, low endotoxin levels, and minimal trifluoroacetic acid (TFA) content. Furthermore, this product features excellent solubility in physiological saline and buffer systems. Since it is chemically robust, you can incorporate it into various products like immediate-release injections or long-acting release (LAR) microsphere formulations without affecting the stability of the peptide chain.

From specialized endocrine research to large-scale pharmaceutical manufacturing of oncology supportive care, this versatile peptide is a staple for modern hormonal regulation. Its consistent pharmacokinetic profile ensures it does not interfere with the intended metabolic pathways of the treatment. As a result, Zyntex provides a dependable foundation for innovation in the acromegaly and carcinoid syndrome markets. Finally, our commitment to safety and batch-to-batch reproducibility helps your brand achieve international regulatory compliance effortlessly.

Key Industrial Applications

This professional-grade peptide is widely utilized in the following sectors:

Technical Specifications